PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
ERIS.NS vs. ORI
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between ERIS.NS and ORI is 0.05, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.1

Performance

ERIS.NS vs. ORI - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Eris Lifesciences Limited (ERIS.NS) and Old Republic International Corporation (ORI). The values are adjusted to include any dividend payments, if applicable.

-5.00%0.00%5.00%10.00%15.00%20.00%25.00%30.00%SeptemberOctoberNovemberDecember2025February
7.04%
12.75%
ERIS.NS
ORI

Key characteristics

Sharpe Ratio

ERIS.NS:

1.31

ORI:

2.32

Sortino Ratio

ERIS.NS:

2.00

ORI:

3.10

Omega Ratio

ERIS.NS:

1.25

ORI:

1.40

Calmar Ratio

ERIS.NS:

1.77

ORI:

4.83

Martin Ratio

ERIS.NS:

5.26

ORI:

13.31

Ulcer Index

ERIS.NS:

8.19%

ORI:

3.08%

Daily Std Dev

ERIS.NS:

32.85%

ORI:

17.43%

Max Drawdown

ERIS.NS:

-55.84%

ORI:

-66.19%

Current Drawdown

ERIS.NS:

-14.50%

ORI:

-3.47%

Fundamentals

Market Cap

ERIS.NS:

₹178.43B

ORI:

$9.18B

EPS

ERIS.NS:

₹24.13

ORI:

$3.24

PE Ratio

ERIS.NS:

54.29

ORI:

11.17

Total Revenue (TTM)

ERIS.NS:

₹27.34B

ORI:

$8.03B

Gross Profit (TTM)

ERIS.NS:

₹15.01B

ORI:

$8.03B

EBITDA (TTM)

ERIS.NS:

₹9.39B

ORI:

$409.30M

Returns By Period

In the year-to-date period, ERIS.NS achieves a -5.22% return, which is significantly lower than ORI's 5.12% return.


ERIS.NS

YTD

-5.22%

1M

4.29%

6M

10.76%

1Y

40.93%

5Y*

24.17%

10Y*

N/A

ORI

YTD

5.12%

1M

6.49%

6M

12.75%

1Y

37.44%

5Y*

18.15%

10Y*

17.08%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

ERIS.NS vs. ORI — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ERIS.NS
The Risk-Adjusted Performance Rank of ERIS.NS is 8282
Overall Rank
The Sharpe Ratio Rank of ERIS.NS is 8383
Sharpe Ratio Rank
The Sortino Ratio Rank of ERIS.NS is 8080
Sortino Ratio Rank
The Omega Ratio Rank of ERIS.NS is 7777
Omega Ratio Rank
The Calmar Ratio Rank of ERIS.NS is 8888
Calmar Ratio Rank
The Martin Ratio Rank of ERIS.NS is 8181
Martin Ratio Rank

ORI
The Risk-Adjusted Performance Rank of ORI is 9494
Overall Rank
The Sharpe Ratio Rank of ORI is 9595
Sharpe Ratio Rank
The Sortino Ratio Rank of ORI is 9292
Sortino Ratio Rank
The Omega Ratio Rank of ORI is 9090
Omega Ratio Rank
The Calmar Ratio Rank of ORI is 9898
Calmar Ratio Rank
The Martin Ratio Rank of ORI is 9494
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

ERIS.NS vs. ORI - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Eris Lifesciences Limited (ERIS.NS) and Old Republic International Corporation (ORI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for ERIS.NS, currently valued at 1.26, compared to the broader market-2.000.002.004.001.262.09
The chart of Sortino ratio for ERIS.NS, currently valued at 1.99, compared to the broader market-6.00-4.00-2.000.002.004.001.992.83
The chart of Omega ratio for ERIS.NS, currently valued at 1.25, compared to the broader market0.501.001.502.001.251.37
The chart of Calmar ratio for ERIS.NS, currently valued at 1.59, compared to the broader market0.002.004.006.001.594.22
The chart of Martin ratio for ERIS.NS, currently valued at 4.82, compared to the broader market0.0010.0020.0030.004.8211.35
ERIS.NS
ORI

The current ERIS.NS Sharpe Ratio is 1.31, which is lower than the ORI Sharpe Ratio of 2.32. The chart below compares the historical Sharpe Ratios of ERIS.NS and ORI, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.501.001.502.002.503.00SeptemberOctoberNovemberDecember2025February
1.26
2.09
ERIS.NS
ORI

Dividends

ERIS.NS vs. ORI - Dividend Comparison

ERIS.NS has not paid dividends to shareholders, while ORI's dividend yield for the trailing twelve months is around 8.52%.


TTM20242023202220212020201920182017201620152014
ERIS.NS
Eris Lifesciences Limited
0.00%0.00%0.00%1.14%0.79%1.44%0.00%0.00%0.00%0.00%0.00%0.00%
ORI
Old Republic International Corporation
8.52%2.93%3.33%7.95%13.75%4.26%8.05%8.65%3.55%3.96%3.97%5.00%

Drawdowns

ERIS.NS vs. ORI - Drawdown Comparison

The maximum ERIS.NS drawdown since its inception was -55.84%, smaller than the maximum ORI drawdown of -66.19%. Use the drawdown chart below to compare losses from any high point for ERIS.NS and ORI. For additional features, visit the drawdowns tool.


-25.00%-20.00%-15.00%-10.00%-5.00%0.00%SeptemberOctoberNovemberDecember2025February
-16.67%
-3.47%
ERIS.NS
ORI

Volatility

ERIS.NS vs. ORI - Volatility Comparison

Eris Lifesciences Limited (ERIS.NS) has a higher volatility of 16.81% compared to Old Republic International Corporation (ORI) at 5.17%. This indicates that ERIS.NS's price experiences larger fluctuations and is considered to be riskier than ORI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


5.00%10.00%15.00%SeptemberOctoberNovemberDecember2025February
16.81%
5.17%
ERIS.NS
ORI

Financials

ERIS.NS vs. ORI - Financials Comparison

This section allows you to compare key financial metrics between Eris Lifesciences Limited and Old Republic International Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Please note, different currencies. ERIS.NS values in INR, ORI values in USD
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab